1. Home
  2. IMNM vs CDZIP Comparison

IMNM vs CDZIP Comparison

Compare IMNM & CDZIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • CDZIP
  • Stock Information
  • Founded
  • IMNM 2006
  • CDZIP N/A
  • Country
  • IMNM United States
  • CDZIP United States
  • Employees
  • IMNM N/A
  • CDZIP 25
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • CDZIP Water Supply
  • Sector
  • IMNM Health Care
  • CDZIP Utilities
  • Exchange
  • IMNM Nasdaq
  • CDZIP Nasdaq
  • Market Cap
  • IMNM 748.3M
  • CDZIP N/A
  • IPO Year
  • IMNM 2020
  • CDZIP N/A
  • Fundamental
  • Price
  • IMNM $8.63
  • CDZIP $17.82
  • Analyst Decision
  • IMNM Strong Buy
  • CDZIP
  • Analyst Count
  • IMNM 5
  • CDZIP 0
  • Target Price
  • IMNM $26.40
  • CDZIP N/A
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • CDZIP N/A
  • Earning Date
  • IMNM 08-11-2025
  • CDZIP N/A
  • Dividend Yield
  • IMNM N/A
  • CDZIP N/A
  • EPS Growth
  • IMNM N/A
  • CDZIP N/A
  • EPS
  • IMNM N/A
  • CDZIP N/A
  • Revenue
  • IMNM $10,938,000.00
  • CDZIP N/A
  • Revenue This Year
  • IMNM N/A
  • CDZIP N/A
  • Revenue Next Year
  • IMNM $310.65
  • CDZIP N/A
  • P/E Ratio
  • IMNM N/A
  • CDZIP N/A
  • Revenue Growth
  • IMNM N/A
  • CDZIP N/A
  • 52 Week Low
  • IMNM $5.15
  • CDZIP N/A
  • 52 Week High
  • IMNM $16.81
  • CDZIP N/A
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 47.25
  • CDZIP 61.63
  • Support Level
  • IMNM $8.46
  • CDZIP $17.25
  • Resistance Level
  • IMNM $9.34
  • CDZIP $17.96
  • Average True Range (ATR)
  • IMNM 0.53
  • CDZIP 0.32
  • MACD
  • IMNM -0.09
  • CDZIP 0.14
  • Stochastic Oscillator
  • IMNM 20.00
  • CDZIP 91.26

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About CDZIP Cadiz Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

Share on Social Networks: